Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

Konstantin Schlick; Florian Hohla; Frank Hamacher; Hubert Hackl; Clemens Hufnagl; Steiner Markus; Teresa Magnes; Simon Peter Gampenrieder; Thomas Melchardt; Stefan Stättner; Cornelia Hauser-Kronberger; Richard Greil; Gabriel Rinnerthaler

doi:10.2144/fsoa-2020-0128

Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

Konstantin Schlick^* (First author), Florian Hohla (Co-author), Frank Hamacher (Co-author), Hubert Hackl, Clemens Hufnagl (Co-author), Steiner Markus, Teresa Magnes (Co-author), Simon Peter Gampenrieder (Co-author), Thomas Melchardt (Co-author), Stefan Stättner, Cornelia Hauser-Kronberger (Co-author), Richard Greil (Co-author), Gabriel Rinnerthaler (Last author)

^*Corresponding author for this work

Research output: Contribution to journal › Original Article (Journal) › peer-review

3 Citations (Web of Science)

Original language	English
Pages (from-to)	FSO644
Journal	FUTURE SCIENCE OA
Volume	7
Issue number	2
DOIs	https://doi.org/10.2144/fsoa-2020-0128
Publication status	Published - 2021

Keywords

SURVIVAL
ADENOCARCINOMA
DIAGNOSIS
CRITERIA
THERAPY
MIR-21

Access to Document

10.2144/fsoa-2020-0128

Cite this

Schlick, K., Hohla, F., Hamacher, F., Hackl, H., Hufnagl, C., Markus, S., Magnes, T., Gampenrieder, S. P., Melchardt, T., Stättner, S., Hauser-Kronberger, C., Greil, R., & Rinnerthaler, G. (2021). Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients. FUTURE SCIENCE OA, 7(2), FSO644. https://doi.org/10.2144/fsoa-2020-0128

@article{3c874ed0dcaa400187e2f0a474a4f6a3,

title = "Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients",

keywords = "SURVIVAL, ADENOCARCINOMA, DIAGNOSIS, CRITERIA, THERAPY, MIR-21",

author = "Konstantin Schlick and Florian Hohla and Frank Hamacher and Hubert Hackl and Clemens Hufnagl and Steiner Markus and Teresa Magnes and Gampenrieder, {Simon Peter} and Thomas Melchardt and Stefan St{\"a}ttner and Cornelia Hauser-Kronberger and Richard Greil and Gabriel Rinnerthaler",

note = "Schlick, Hohla, Hufnagl, Steiner, Magnes, Gampenrieder, Melchardt, Greil, Rinnerthaler: Paracelsus Med Univ Salzburg, Oncol Ctr, Med Dept 3, Salzburg, Austria; Staettner: Paracelsus Med Univ Salzburg, Dept Surg, Salzburg, Austria; Hauser-Kronberger: Paracelsus Med Univ Salzburg, Dept Pathol, Salzburg, Austria",

year = "2021",

doi = "10.2144/fsoa-2020-0128",

language = "English",

volume = "7",

pages = "FSO644",

journal = "FUTURE SCIENCE OA",

issn = "2056-5623",

number = "2",

}

Schlick, K, Hohla, F, Hamacher, F, Hackl, H, Hufnagl, C, Markus, S, Magnes, T , Gampenrieder, SP , Melchardt, T, Stättner, S, Hauser-Kronberger, C, Greil, R & Rinnerthaler, G 2021, 'Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients', FUTURE SCIENCE OA, vol. 7, no. 2, pp. FSO644. https://doi.org/10.2144/fsoa-2020-0128

Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients. / Schlick, Konstantin (First author); Hohla, Florian (Co-author); Hamacher, Frank (Co-author) et al.
In: FUTURE SCIENCE OA, Vol. 7, No. 2, 2021, p. FSO644.

Research output: Contribution to journal › Original Article (Journal) › peer-review

TY - JOUR

T1 - Overcoming negative predictions of microRNA expressions to gemcitabine response with FOLFIRINOX in advanced pancreatic cancer patients

AU - Schlick, Konstantin

AU - Hohla, Florian

AU - Hamacher, Frank

AU - Hackl, Hubert

AU - Hufnagl, Clemens

AU - Markus, Steiner

AU - Magnes, Teresa

AU - Gampenrieder, Simon Peter

AU - Melchardt, Thomas

AU - Stättner, Stefan

AU - Hauser-Kronberger, Cornelia

AU - Greil, Richard

AU - Rinnerthaler, Gabriel

N1 - Schlick, Hohla, Hufnagl, Steiner, Magnes, Gampenrieder, Melchardt, Greil, Rinnerthaler: Paracelsus Med Univ Salzburg, Oncol Ctr, Med Dept 3, Salzburg, Austria; Staettner: Paracelsus Med Univ Salzburg, Dept Surg, Salzburg, Austria; Hauser-Kronberger: Paracelsus Med Univ Salzburg, Dept Pathol, Salzburg, Austria

PY - 2021

Y1 - 2021

KW - SURVIVAL

KW - ADENOCARCINOMA

KW - DIAGNOSIS

KW - CRITERIA

KW - THERAPY

KW - MIR-21

U2 - 10.2144/fsoa-2020-0128

DO - 10.2144/fsoa-2020-0128

M3 - Original Article (Journal)

C2 - 33437513

SN - 2056-5623

VL - 7

SP - FSO644

JO - FUTURE SCIENCE OA

JF - FUTURE SCIENCE OA

IS - 2

ER -